Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

ACCENDRA HEALTH INC.

Filed by ACCENDRA HEALTH INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 16, 2025
Income
Not reported
Expenses
$200,000.00
Filing UUID
bb8820d6-256d-4edd-9b2f-ba2ebd3e1f48
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the medical-surgical supply chain including domestic and near-shore production including the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417); Promoting Resilient Supply Chains Act of 2025 (S. 257).

Literal federal measure citations: S. 257

MMM · Medicare/Medicaid

Issues related to patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2024, 118th Congress H.R. 7829, S. 3821); the extension of telehealth flexibilities (see Public Law No. 119-4); and promoting electronic prescribing platforms.

Literal federal measure citations: H.R. 2005, H.R. 7829, S. 3821

TRD · Trade (domestic/foreign)

Issues related to the medical-surgical supply chain including domestic and near-shore production.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.